Back to top
more

Smith & Nephew SNATS (SNN)

(Delayed Data from NYSE)

$29.13 USD

29.13
1,106,201

-0.17 (-0.58%)

Updated Aug 27, 2026 04:00 PM ET

Pre-Market: $29.04 -0.09 (-0.31%) 8:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 248)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

by Zacks Equity Research

Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.

    Zacks Equity Research

    Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew

    by Zacks Equity Research

    Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic and Smith & Nephew

      Zacks Equity Research

      MedTech Industry Outlook - October 2017

      by Zacks Equity Research

      The Trump administration has not come up with any concrete plan to replace the MedTech tax as of yet.

        Zacks Equity Research

        Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

        by Zacks Equity Research

        Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

          Zacks Equity Research

          The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

          by Zacks Equity Research

          The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

            Zacks Equity Research

            Top MedTech Stocks Safe from Graham-Cassidy Repeal Bill

            by Zacks Equity Research

            The investment climate for medical device majors has become increasingly volatile due to political potshots in Capitol Hill, for and against Obamacare.

              Zacks Equity Research

              Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy

              by Zacks Equity Research

              The fate of Obamacare will be decided on Sep. 30. No matter what the future holds, the day will provide investors a clear picture of where the MedTech industry is headed.

                Zacks Equity Research

                MedTech Hangs in the Balance as Obamacare Skinny Repeal Fails

                by Zacks Equity Research

                Any retention or repeal of Obamacare will actually create a vicious circle within the MedTech sector.

                  Swarup Gupta headshot

                  5 British Stocks to Profit From a Weak Pound Sterling

                  by Swarup Gupta

                  Companies exporting products and services stand to benefit from a weaker pound.

                    Zacks Equity Research

                    3 MedTech Stocks Set to Rally in the Second Half

                    by Zacks Equity Research

                    The wide gamut of Medical Device presents interesting choice for investors to profit from rally in the second half of 2017.